Uncoupling nNOS-PSD-95 in mPFC inhibits morphine priming-induced reinstatement after extinction training

Xiao-Lin Kou1, Yan Tao1, Jia-Yun Xian1

  • 1Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, People's Republic of China.

Insights

Drug relapse is a major challenge. Scientists found that blocking the link between nNOS and PSD-95 in the medial prefrontal cortex can prevent morphine relapse in mice, potentially by restoring CREB function.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Drug abuse relapse rates remain critically high, posing a significant public health challenge.
  • Environmental cues are known triggers for relapse, but the underlying molecular mechanisms are not fully understood.
  • The medial prefrontal cortex (mPFC) is implicated in drug-seeking behaviors and relapse.

Purpose of the Study:

  • To investigate the role of neuronal nitric oxide synthase (nNOS) and postsynaptic density-95 (PSD-95) coupling in the mPFC in morphine relapse.
  • To explore the potential of targeting the nNOS-PSD-95 interaction to prevent drug-induced reinstatement.

Main Methods:

  • Utilized a morphine conditioned place preference (CPP) model in mice.
  • Examined nNOS-PSD-95 coupling and c-Fos expression in the mPFC after morphine CPP extinction.
  • Administered ZL006 to dissociate nNOS-PSD-95 and assessed its effect on morphine-priming-induced reinstatement.
  • Investigated the impact on cAMP-response element binding protein (CREB) phosphorylation in the mPFC.

Main Results:

  • Morphine CPP extinction led to increased nNOS-PSD-95 coupling and c-Fos expression in the mPFC.
  • Dissociation of nNOS-PSD-95 by ZL006 significantly inhibited the reinstatement of morphine CPP.
  • Morphine exposure after extinction training resulted in reduced CREB phosphorylation, which was reversed by uncoupling nNOS-PSD-95.
  • The effects of ZL006 were dependent on its interaction with nNOS-PSD-95.

Conclusions:

  • The nNOS-PSD-95 interaction in the mPFC is crucial for the reinstatement of morphine-induced CPP.
  • Disrupting this interaction may prevent relapse by normalizing CREB dysfunction.
  • Targeting the nNOS-PSD-95 pathway presents a potential therapeutic strategy for preventing drug abuse relapse.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
763
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
826
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K